Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Liver Transplantation | Research

The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients

Authors: Zhendong Ding, Mian Ge, Yuexiang Tan, Chaojin Chen, Ziqing Hei

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

The triglyceride-glucose (TyG) index, identified as a reliable indicator of insulin resistance (IR), was reported to be associated with stroke recurrence and morbidity in the general population and critically ill patients. However, the relationship in liver transplantation (LT) recipients remains unknown. This study aimed to investigate the correlation between the TyG index and post-LT stroke along with all-cause mortality and further assess the influence of IR on the LT recipients’ prognosis.

Methods

The retrospective cohort study enrolled 959 patients who underwent LT at a university-based medical centre between January 2015 and January 2021. The participants were divided into three groups according to their TyG index tertiles. The primary outcome was post-LT stroke. Multivariate logistic regression, COX proportional hazards regression, and restricted cubic spline RCS were used to examine the association between the TyG index and outcomes in LT recipients.

Results

With a median TyG index of 8.23 (7.78–8.72), 780 (87.18% males) patients were eventually included. The incidence of post-LT stroke was 5.38%, and the in-hospital, 1-year, and 3-year mortality rates were 5.54%, 13.21%, and 15.77%, respectively. Multivariate regression analysis showed an independent association between the TyG index and an increased risk of post-LT stroke [adjusted odds ratio (aOR), 3.398 (95% confidence interval [CI]: 1.371–8.426) P = 0. 008], in-hospital mortality [adjusted hazard ratio (aHR), 2.326 (95% CI: 1.089–4.931) P = 0.025], 1-year mortality [aHR, 1.668 (95% CI: 1.024–2.717) P = 0.039], and 3-year mortality [aHR, 1.837 (95% CI: 1.445–2.950) P = 0.012]. Additional RCS analysis also suggested a linear increase in the risk of postoperative stroke with elevated TyG index (P for nonlinearity = 0.480).

Conclusions

The TyG index may be a valuable and reliable indicator for assessing stroke risk and all-cause mortality in patients undergoing LT, suggesting its potential relevance in improving risk stratification during the peri-LT period.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsochatzis E, Coilly A, Nadalin S, Levistky J, Tokat Y, Ghobrial M, Klinck J, Berenguer M. International Liver Transplantation Consensus Statement on end-stage Liver Disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation. 2019;103:45–56.PubMedCrossRef Tsochatzis E, Coilly A, Nadalin S, Levistky J, Tokat Y, Ghobrial M, Klinck J, Berenguer M. International Liver Transplantation Consensus Statement on end-stage Liver Disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation. 2019;103:45–56.PubMedCrossRef
2.
go back to reference Pollok JM, Tinguely P, Berenguer M, Niemann CU, Raptis DA, Spiro M, collaborative EROo. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023;8:81–94.PubMedCrossRef Pollok JM, Tinguely P, Berenguer M, Niemann CU, Raptis DA, Spiro M, collaborative EROo. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023;8:81–94.PubMedCrossRef
3.
go back to reference Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Miller E, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2018 Annual Data Report: liver. Am J Transplant. 2020;20(Suppl s1):193–299.PubMedCrossRef Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Miller E, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2018 Annual Data Report: liver. Am J Transplant. 2020;20(Suppl s1):193–299.PubMedCrossRef
4.
go back to reference Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW. Perioperative care of patients at high risk for Stroke during or after non-cardiac, non-neurologic Surgery: consensus statement from the Society for Neuroscience in Anesthesiology and critical Care*. J Neurosurg Anesthesiol. 2014;26:273–85.PubMedCrossRef Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW. Perioperative care of patients at high risk for Stroke during or after non-cardiac, non-neurologic Surgery: consensus statement from the Society for Neuroscience in Anesthesiology and critical Care*. J Neurosurg Anesthesiol. 2014;26:273–85.PubMedCrossRef
5.
go back to reference Jin X, Li P, Michalski D, Li S, Zhang Y, Jolkkonen J, Cui L, Didwischus N, Xuan W, Boltze J. Perioperative Stroke: a perspective on challenges and opportunities for experimental treatment and diagnostic strategies. CNS Neurosci Ther. 2022;28:497–509.PubMedPubMedCentralCrossRef Jin X, Li P, Michalski D, Li S, Zhang Y, Jolkkonen J, Cui L, Didwischus N, Xuan W, Boltze J. Perioperative Stroke: a perspective on challenges and opportunities for experimental treatment and diagnostic strategies. CNS Neurosci Ther. 2022;28:497–509.PubMedPubMedCentralCrossRef
6.
go back to reference Fagiuoli S, Colli A, Bruno R, Craxi A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P, Group AST. (2014) Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 60: 1075–1089. Fagiuoli S, Colli A, Bruno R, Craxi A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P, Group AST. (2014) Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 60: 1075–1089.
7.
go back to reference Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical function, physical activity, and Quality of Life after Liver Transplantation. Liver Transpl. 2020;26:702–8.PubMedPubMedCentralCrossRef Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical function, physical activity, and Quality of Life after Liver Transplantation. Liver Transpl. 2020;26:702–8.PubMedPubMedCentralCrossRef
8.
go back to reference Kwon H, Shin S, Baek CH, Chang JY, Kang DW, Kwon SU, Kim JS, Kim BJ. Characteristics of Stroke after liver and kidney transplantation. Front Neurol. 2023;14:1123518.PubMedPubMedCentralCrossRef Kwon H, Shin S, Baek CH, Chang JY, Kang DW, Kwon SU, Kim JS, Kim BJ. Characteristics of Stroke after liver and kidney transplantation. Front Neurol. 2023;14:1123518.PubMedPubMedCentralCrossRef
9.
go back to reference Benesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messe SR, Mijalski C, Nelson MT, Power M, Welch BG, American Heart Association, Stroke C, Council on Arteriosclerosis T, Vascular B, Council C, Stroke N, Council on Clinical C, Council on E, Prevention., (2021) Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association. Circulation 143: e923-e946. Benesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messe SR, Mijalski C, Nelson MT, Power M, Welch BG, American Heart Association, Stroke C, Council on Arteriosclerosis T, Vascular B, Council C, Stroke N, Council on Clinical C, Council on E, Prevention., (2021) Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association. Circulation 143: e923-e946.
10.
go back to reference Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.PubMedCrossRef Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.PubMedCrossRef
11.
go back to reference Hoshino T, Mizuno T, Ishizuka K, Takahashi S, Arai S, Toi S, Kitagawa K. Triglyceride-glucose index as a prognostic marker after ischemic Stroke or transient ischemic Attack: a prospective observational study. Cardiovasc Diabetol. 2022;21:264.PubMedPubMedCentralCrossRef Hoshino T, Mizuno T, Ishizuka K, Takahashi S, Arai S, Toi S, Kitagawa K. Triglyceride-glucose index as a prognostic marker after ischemic Stroke or transient ischemic Attack: a prospective observational study. Cardiovasc Diabetol. 2022;21:264.PubMedPubMedCentralCrossRef
12.
go back to reference Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–97.PubMedCrossRef Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–97.PubMedCrossRef
13.
go back to reference Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19:155.PubMedPubMedCentralCrossRef Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19:155.PubMedPubMedCentralCrossRef
14.
go back to reference Zhou D, Liu XC, Kenneth L, Huang YQ, Feng YQ. A Non-linear Association of triglyceride Glycemic Index with Cardiovascular and all-cause Mortality among patients with Hypertension. Front Cardiovasc Med. 2021;8:778038.PubMedCrossRef Zhou D, Liu XC, Kenneth L, Huang YQ, Feng YQ. A Non-linear Association of triglyceride Glycemic Index with Cardiovascular and all-cause Mortality among patients with Hypertension. Front Cardiovasc Med. 2021;8:778038.PubMedCrossRef
15.
go back to reference Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, Lin X, Guo Q, Wang Y, Chen L, Li W, Li S, Chen K, Fang Y. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21:128.PubMedPubMedCentralCrossRef Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, Lin X, Guo Q, Wang Y, Chen L, Li W, Li S, Chen K, Fang Y. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21:128.PubMedPubMedCentralCrossRef
16.
go back to reference Carlson GL. Insulin resistance and glucose-induced thermogenesis in critical Illness. Proc Nutr Soc. 2001;60:381–8.PubMedCrossRef Carlson GL. Insulin resistance and glucose-induced thermogenesis in critical Illness. Proc Nutr Soc. 2001;60:381–8.PubMedCrossRef
18.
go back to reference Zauner A, Nimmerrichter P, Anderwald C, Bischof M, Schiefermeier M, Ratheiser K, Schneeweiss B, Zauner C. Severity of insulin resistance in critically ill medical patients. Metabolism. 2007;56:1–5.PubMedCrossRef Zauner A, Nimmerrichter P, Anderwald C, Bischof M, Schiefermeier M, Ratheiser K, Schneeweiss B, Zauner C. Severity of insulin resistance in critically ill medical patients. Metabolism. 2007;56:1–5.PubMedCrossRef
19.
go back to reference Bhat M, Rabindranath M, Chara BS, Simonetto DA. Artificial intelligence, machine learning, and deep learning in liver transplantation. J Hepatol. 2023;78:1216–33.PubMedCrossRef Bhat M, Rabindranath M, Chara BS, Simonetto DA. Artificial intelligence, machine learning, and deep learning in liver transplantation. J Hepatol. 2023;78:1216–33.PubMedCrossRef
20.
go back to reference Lee WG, Wells CI, McCall JL, Murphy R, Plank LD. Prevalence of Diabetes in liver Cirrhosis: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35:e3157.PubMedCrossRef Lee WG, Wells CI, McCall JL, Murphy R, Plank LD. Prevalence of Diabetes in liver Cirrhosis: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35:e3157.PubMedCrossRef
23.
go back to reference Liu D, Yang K, Gu H, Li Z, Wang Y, Wang Y. Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic Stroke and type 2 Diabetes Mellitus. Cardiovasc Diabetol. 2022;21:280.PubMedPubMedCentralCrossRef Liu D, Yang K, Gu H, Li Z, Wang Y, Wang Y. Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic Stroke and type 2 Diabetes Mellitus. Cardiovasc Diabetol. 2022;21:280.PubMedPubMedCentralCrossRef
24.
go back to reference Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, Liao L, Guo Q, Zhang X, Li W, Zhang K, Liao Y, Fang Y. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary Heart Disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22:10.PubMedPubMedCentralCrossRef Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, Liao L, Guo Q, Zhang X, Li W, Zhang K, Liao Y, Fang Y. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary Heart Disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22:10.PubMedPubMedCentralCrossRef
25.
go back to reference Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, Zeng Y, Yu F. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic Stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22:138.PubMedPubMedCentralCrossRef Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, Zeng Y, Yu F. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic Stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22:138.PubMedPubMedCentralCrossRef
26.
go back to reference (1989) Stroke–1989. Recommendations on Stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular disorders. Stroke 20: 1407–31. (1989) Stroke–1989. Recommendations on Stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular disorders. Stroke 20: 1407–31.
27.
28.
go back to reference Jorgensen ME, Torp-Pedersen C, Gislason GH, Jensen PF, Berger SM, Christiansen CB, Overgaard C, Schmiegelow MD, Andersson C. Time elapsed after ischemic Stroke and risk of adverse cardiovascular events and mortality following elective noncardiac Surgery. JAMA. 2014;312:269–77.PubMedCrossRef Jorgensen ME, Torp-Pedersen C, Gislason GH, Jensen PF, Berger SM, Christiansen CB, Overgaard C, Schmiegelow MD, Andersson C. Time elapsed after ischemic Stroke and risk of adverse cardiovascular events and mortality following elective noncardiac Surgery. JAMA. 2014;312:269–77.PubMedCrossRef
29.
go back to reference Lewis MB, Howdle PD. Neurologic Complications of liver transplantation in adults. Neurology. 2003;61:1174–8.PubMedCrossRef Lewis MB, Howdle PD. Neurologic Complications of liver transplantation in adults. Neurology. 2003;61:1174–8.PubMedCrossRef
30.
go back to reference Bonham CA, Dominguez EA, Fukui MB, Paterson DL, Pankey GA, Wagener MM, Fung JJ, Singh N. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998;66:1596–604.PubMedCrossRef Bonham CA, Dominguez EA, Fukui MB, Paterson DL, Pankey GA, Wagener MM, Fung JJ, Singh N. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998;66:1596–604.PubMedCrossRef
31.
go back to reference Zhou Y, Pan Y, Yan H, Wang Y, Li Z, Zhao X, Li H, Meng X, Wang C, Liu L, Wang Y. Triglyceride glucose index and prognosis of patients with ischemic Stroke. Front Neurol. 2020;11:456.PubMedPubMedCentralCrossRef Zhou Y, Pan Y, Yan H, Wang Y, Li Z, Zhao X, Li H, Meng X, Wang C, Liu L, Wang Y. Triglyceride glucose index and prognosis of patients with ischemic Stroke. Front Neurol. 2020;11:456.PubMedPubMedCentralCrossRef
32.
go back to reference Zheng R, Qian S, Shi Y, Lou C, Xu H, Pan J. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22:307.PubMedPubMedCentralCrossRef Zheng R, Qian S, Shi Y, Lou C, Xu H, Pan J. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22:307.PubMedPubMedCentralCrossRef
33.
go back to reference Chang Y, Jeon J, Song TJ, Kim J. Association of triglyceride-glucose index with prognosis of COVID-19: a population-based study. J Infect Public Health. 2022;15:837–44.PubMedPubMedCentralCrossRef Chang Y, Jeon J, Song TJ, Kim J. Association of triglyceride-glucose index with prognosis of COVID-19: a population-based study. J Infect Public Health. 2022;15:837–44.PubMedPubMedCentralCrossRef
34.
go back to reference Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, Jiang B, Wang Y, Chen L. The impact of triglyceride-glucose index on ischemic Stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22:2.PubMedPubMedCentralCrossRef Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, Jiang B, Wang Y, Chen L. The impact of triglyceride-glucose index on ischemic Stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22:2.PubMedPubMedCentralCrossRef
35.
go back to reference Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, Tian X, Wang P, Meng X, Wu S, Wang Y, Wang Y. Triglyceride-glucose index and the risk of Stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021;20:46.PubMedPubMedCentralCrossRef Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, Tian X, Wang P, Meng X, Wu S, Wang Y, Wang Y. Triglyceride-glucose index and the risk of Stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021;20:46.PubMedPubMedCentralCrossRef
36.
go back to reference Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic Cardiovascular Diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20:76.PubMedPubMedCentralCrossRef Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic Cardiovascular Diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20:76.PubMedPubMedCentralCrossRef
37.
go back to reference Bailey P, Vergis N, Allison M, Riddell A, Massey E. Psychosocial evaluation of candidates for solid organ transplantation. Transplantation. 2021;105:e292–e302.PubMedCrossRef Bailey P, Vergis N, Allison M, Riddell A, Massey E. Psychosocial evaluation of candidates for solid organ transplantation. Transplantation. 2021;105:e292–e302.PubMedCrossRef
38.
go back to reference Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N, Gao Y, Zheng J. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal Disease patients with coronary artery Disease. Cardiovasc Diabetol. 2023;22:292.PubMedPubMedCentralCrossRef Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N, Gao Y, Zheng J. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal Disease patients with coronary artery Disease. Cardiovasc Diabetol. 2023;22:292.PubMedPubMedCentralCrossRef
39.
40.
go back to reference Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, Hanania NA. Association of Triglyceride-Glucose Index and Lung Health: a Population-based study. Chest. 2021;160:1026–34.PubMedPubMedCentralCrossRef Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, Hanania NA. Association of Triglyceride-Glucose Index and Lung Health: a Population-based study. Chest. 2021;160:1026–34.PubMedPubMedCentralCrossRef
41.
go back to reference Markus MRP, Rospleszcz S, Ittermann T, Baumeister SE, Schipf S, Siewert-Markus U, Lorbeer R, Storz C, Ptushkina V, Peters A, Meisinger C, Bamberg F, Nauck M, Bahls M, Volzke H, Felix SB, Bulow R, Rathmann W, Dorr M. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart. Cardiovasc Diabetol. 2019;18:145.PubMedPubMedCentralCrossRef Markus MRP, Rospleszcz S, Ittermann T, Baumeister SE, Schipf S, Siewert-Markus U, Lorbeer R, Storz C, Ptushkina V, Peters A, Meisinger C, Bamberg F, Nauck M, Bahls M, Volzke H, Felix SB, Bulow R, Rathmann W, Dorr M. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart. Cardiovasc Diabetol. 2019;18:145.PubMedPubMedCentralCrossRef
42.
go back to reference Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in Cardiovascular Disease development. Nat Rev Endocrinol. 2014;10:293–302.PubMedCrossRef Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in Cardiovascular Disease development. Nat Rev Endocrinol. 2014;10:293–302.PubMedCrossRef
43.
go back to reference Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of Cardiovascular Disease. Cardiovasc Diabetol. 2018;17:122.PubMedPubMedCentralCrossRef Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of Cardiovascular Disease. Cardiovasc Diabetol. 2018;17:122.PubMedPubMedCentralCrossRef
44.
go back to reference van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.PubMedCrossRef van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.PubMedCrossRef
45.
46.
go back to reference Brown E, Ozawa K, Moccetti F, Vinson A, Hodovan J, Nguyen TA, Bader L, Lopez JA, Kievit P, Shaw GD, Chung DW, Osborn W, Fu X, Chen J, Lindner JR. Arterial platelet adhesion in atherosclerosis-prone arteries of obese, insulin-resistant nonhuman Primates. J Am Heart Assoc. 2021;10:e019413.PubMedPubMedCentralCrossRef Brown E, Ozawa K, Moccetti F, Vinson A, Hodovan J, Nguyen TA, Bader L, Lopez JA, Kievit P, Shaw GD, Chung DW, Osborn W, Fu X, Chen J, Lindner JR. Arterial platelet adhesion in atherosclerosis-prone arteries of obese, insulin-resistant nonhuman Primates. J Am Heart Assoc. 2021;10:e019413.PubMedPubMedCentralCrossRef
48.
go back to reference Wang X, Feng B, Huang Z, Cai Z, Yu X, Chen Z, Cai Z, Chen G, Wu S, Chen Y. Relationship of cumulative exposure to the triglyceride-glucose index with ischemic Stroke: a 9-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2022;21:66.PubMedPubMedCentralCrossRef Wang X, Feng B, Huang Z, Cai Z, Yu X, Chen Z, Cai Z, Chen G, Wu S, Chen Y. Relationship of cumulative exposure to the triglyceride-glucose index with ischemic Stroke: a 9-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2022;21:66.PubMedPubMedCentralCrossRef
Metadata
Title
The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients
Authors
Zhendong Ding
Mian Ge
Yuexiang Tan
Chaojin Chen
Ziqing Hei
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02113-x

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.